The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

10026–10050 of 17785

  • LowFDA (Drugs)·D-0230-2018·2018-01-31

    Mylan Recalls Bupropion HCL Extended-Release Tablets Due to Impurities

    Mylan Pharmaceuticals is voluntarily recalling specific bottles of bupropion HCL extended-release tablets due to out-of-specification impurities found during routine stability testing.

    Product
    bupPROPion HCL Extended-Release Tablets, USP (XL) 300 mg, 500-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. NDC: 0378-2009-05
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0227-2018·2018-01-24

    Rugby Aller-chlor Syrup Recalled for Microbial Contamination

    Pharmatech LLC is recalling Rugby Aller-chlor syrup due to microbial contamination, including yeast and potential B. cepacia.

    Product
    Rugby Aller-chlor (Chlorpheniramine Maleate Syrup, USP), 2 mg, 4 fl. oz. (120 mL) plastic bottles, Distributed by: Rugby Laboratories 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152 USA --- NDC: 0536-1025-47, Manufactured by PharmaTech LLC, Davie FL
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0224-2018·2018-01-24

    Rugby Diocto Liquid Recalled for Microbial Contamination

    PharmaTech LLC is recalling Rugby Diocto Liquid due to microbial contamination, including yeast and potential B. cepacia.

    Product
    Rugby Diocto Liquid, Docusate Sodium 50 mg/ 5 mL, Stool Softener Laxative, One Pint (473 mL) plastic bottles, Dist. by: Rugby Laboratories, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 --- NDC: 0536-0590-85, Manufactured by PharmaTech LLC, Davie, FL
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0221-2018·2018-01-24

    Pharmedium Recalls Superpotent Phenylephrine Syringes Nationwide

    Pharmedium Services is voluntarily recalling 2,390 syringes of Phenylephrine HCL 100 mcg/mL due to a superpotent drug classification.

    Product
    Phenylephrine HCL 100 mcg per mL (1 mg/10 mL) in 0.9% Sodium Chloride 10 mL syringes, PharMEDium Services, LLC 913 N Davis Ave Cleveland, MS, NDC 71019-263-20
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0225-2018·2018-01-24

    Rugby Diocto Syrup Recalled for Microbial Contamination

    Pharmatech LLC is recalling Rugby Diocto Syrup due to microbial contamination, including the presence of yeast and potential B. cepacia.

    Product
    Rugby Diocto Syrup, Docusate Sodium 60 mg/15 mL, Stool Softener Laxative, One Pint (473 mL) plastic bottles, Dist. by: Rugby Laboratories, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152. NDC: 0536-1001-85, Manufactured by PharmaTech LLC, Davie, FL
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0226-2018·2018-01-24

    Rugby Senexon Liquid Recalled for Microbial Contamination

    Pharmatech LLC is recalling Rugby Senexon Liquid due to microbial contamination, including yeast and potential B. cepacia.

    Product
    Rugby Senexon Liquid Natural Vegetable Stimulant,(Sennosides) 8.8 mg, 8 fl oz (237 mL) plastic bottles, Distributed by: Rugby Laboratories, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152 --- NDC 0536-1000-59 ; ALSO LABELED AS Major Senna Syrup Natural Vegetable Laxative
    Category
    Drug
    Distribution
    1 state
  • HighFDA (Drugs)·D-0228-2018·2018-01-24

    Unichem Recalls Divalproex Sodium Tablets Due to Metronidazole Contamination

    Unichem Pharmaceuticals is recalling Divalproex Sodium tablets because metronidazole powder was found in one bottle. The product was distributed nationwide.

    Product
    DIVALPROEX SODIUM — DIVALPROEX SODIUM (DIVALPROEX SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0220-2018·2018-01-24

    Pharmedium Recalls Subpotent Ephedrine Sulfate Syringes Nationwide

    Pharmedium Services is recalling 5,002 pre-filled ephedrine sulfate syringes nationwide because the drug was subpotent. The voluntary recall was initiated in October 2017.

    Product
    ePHEDrine Sulfate In 0.9% Sodium Chloride, 5 mg per mL (50 mg per 10 mL), 10 mL Total Volume pre-filled syringes, packaged in a) 5-count cartons, NDC 71030-0003-10 and NDC 71030-0003-20, and b) 25-count cartons, NDC 71030-0003-21 and NDC 71030-0003-12, Rx Only, PharMEDium Servic
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0218-2018·2018-01-24

    Shiseido Future Solutions LX Triple Points Bonus Recalled for GMP Deviations

    Shiseido America Inc. is recalling Shiseido Future Solutions LX Triple Points Bonus because the manufacturing of the active pharmaceutical ingredient did not meet GMP and quality requirements.

    Product
    Shiseido Future Solutions LX Triple Points Bonus contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022, NDC 58411-256-60
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0215-2018·2018-01-24

    Shiseido Sunscreen Recalled for Manufacturing Quality Deviations

    Shiseido America Inc. is recalling Future Solution LX Universal Defense SPF 50+ sunscreen because the manufacturing of active ingredient material did not meet GMP and quality requirements.

    Product
    Shiseido Future Solution LX Universal Defense SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in a) 2mL, b) 15 mL and c) 50 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022. NDC 58411-256-60
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0214-2018·2018-01-24

    Shiseido Recalls bareMinerals Sunscreen Lotion Due to GMP Deviations

    Shiseido America Inc. is recalling bareMinerals Broad Spectrum SPF 50 Daily Prep Lotion because the manufacturing of active pharmaceutical ingredients did not meet GMP and quality requirements.

    Product
    bareMinerals Broad Spectrum SPF 50 Daily Prep Lotion (zinc oxide 23.8%, titanium dioxide 4.1%), 40 mL/1.35 fl. oz. bottle, Dist. by Bare Escentuals Beauty, Inc. SF, CA 94105 USA, NDC 98132-761-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0222-2018·2018-01-24

    AvKARE Recalls Lovastatin Tablets Due to Dissolution Failures

    AvKARE Inc. is recalling 237 cartons of Lovastatin Tablets USP, 40 mg, because annual stability testing revealed low dissolution results.

    Product
    Lovastatin Tablets USP, 40 mg, 50 Tablets (5x10) Unit Dose carton, Rx only, Manufactured for AvKARE, Inc. Pulaski, TN 38478, NDC 50268-512-15.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0216-2018·2018-01-24

    Shiseido Future Solution LX Discovery Set Recalled for GMP Deviations

    Shiseido America Inc. is recalling the Future Solution LX Discovery Set because the manufacturing of active pharmaceutical ingredients did not meet GMP and quality requirements.

    Product
    Shiseido Future Solution LX Discovery Set contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022,
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0217-2018·2018-01-24

    Shiseido Eye and Lip Collection Recalled for GMP Deviations

    Shiseido America Inc. is recalling the Future Solution LX Luxurious Eye & Lip Collection because the manufacturing of active pharmaceutical ingredients did not meet GMP and quality requirements.

    Product
    Shiseido Future Solution LX Luxurious Eye & Lip Collection contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0219-2018·2018-01-24

    Shionogi Recalls Mefenamic Acid Capsules Due to Foreign Particles

    Shionogi Inc. is recalling 968 bottles of Mefenamic Acid Capsules, 250 mg, due to the presence of black particles found during routine stability testing.

    Product
    Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OH 45040, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ 07981, NDC 66993-070-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0208-2018·2018-01-17

    Teva Recalls Moexipril Hydrochloride Tablets Due to Impurity Test Failure

    Teva Pharmaceuticals is recalling specific bottles of Moexipril Hydrochloride and Hydrochlorothiazide tablets because routine stability testing found high levels of a degradation impurity.

    Product
    Moexipril Hydrochloride and Hydrocholorothiazide Tablets USP, 7.5 mg/12.5 mg, 100-count bottle, Rx only, Distributed By: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5213-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0212-2018·2018-01-17

    Pfizer Recalls Atorvastatin Tablets Due to Microbial Contamination

    Pfizer is recalling specific export-only batches of atorvastatin calcium tablets due to microbial contamination. No product was distributed in the United States.

    Product
    FOR EXPORT ONLY Atorvastatin calcium Film-Coated Tablets a) 80 mg SMT Tabs Bulk, b) 40 mg SMT G EP PR KR, c) 20 mg SMT G EP PR, d) 20 mg SMT G EP PR KR, FOR MANUFACTURING, PROCESSING OR REPACKAGING
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-0195-2018·2018-01-17

    KRS Global Biotechnology Recalls Sermorelin Vials Due to Labeling Errors

    KRS Global Biotechnology is recalling 597 vials of Sermorelin and related peptides because the Beyond Use Date exceeds the expiration of at least one ingredient.

    Product
    Sermorelin, 3 mg/ GHRP6, 3 mg/GHRP2, 3 mg, Vial - Lyophilized, For SC Use, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0176-2018·2018-01-17

    KRS Global Biotechnology Recalls Human Chorionic Gonadotropin Due to Labeling Errors

    KRS Global Biotechnology is recalling 2,239 vials of Human Chorionic Gonadotropin because the Beyond Use Date exceeds the expiration date of at least one ingredient.

    Product
    Human Chorionic Gonadotropin 6,000 iu/Vial, For SC Use -Lyophilized, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0168-2018·2018-01-17

    FDA Recalls Bi-Est Cream Due to Expired Ingredient Dates

    KRS Global Biotechnology is recalling 300 jars of Bi-Est Cream because the Beyond Use Date exceeds the expiration date of at least one ingredient.

    Product
    Bi-Est (Estriol/Estradiol) (80/20) + Progesterone 7.5 mg/200 mg Cream packaged in jars, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd Boca Raton, FL 33487.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0184-2018·2018-01-17

    KRS Global Biotechnology Recalls Methylene Blue Injectable Vials for Labeling Errors

    KRS Global Biotechnology is recalling 696 vials of Methylene Blue (PF) 10 mg/mL Injectable due to incorrect or missing lot and expiration dates.

    Product
    Methylene Blue (PF) 10 mg/mL (1%) Injectable Vial, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0204-2018·2018-01-17

    KRS Global Biotechnology Recalls Vitamin 9 A/B Lyophilized Vials Due to Labeling Errors

    KRS Global Biotechnology is recalling 3,612 vials of Vitamin 9 A/B Lyophilized Vials because the Beyond Use Date exceeds the expiration date of at least one ingredient.

    Product
    Vitamin 9 A/B Lyophilized Vial, For IM Use, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0161-2018·2018-01-17

    KRS Global Biotechnology Recalls Anastrozole 0.5 mg Capsules for Labeling Errors

    KRS Global Biotechnology is recalling 15,700 capsules of Anastrozole 0.5 mg due to incorrect or missing lot and expiration dates.

    Product
    Anastrozole 0.5 mg Capsules, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.
    Category
    Drug
    Distribution
    Distributed nationwide